Antibody Drug Conjugates

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Antibody Drug Conjugates ; volume:41 ; number:06 ; year:2020 ; pages:889-892
Indian journal of medical & paediatric oncology ; 41, Heft 06 (2020), 889-892

Contributor: Bala, Stalin
Prasad, Siva K.

DOI: 10.4103/ijmpo.ijmpo_313_20

URN: urn:nbn:de:101:1-2021080510503547546196

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:55 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bala, Stalin
Prasad, Siva K.

Other Objects (12)

Antibody–drug conjugates in ovarian cancer

Antibody–drug conjugates—the magic bullet?

Current Status: Site-Specific Antibody Drug Conjugates

Fate of Antibody-Drug Conjugates in Cancer Cells

Antibody–drug conjugates (ADCs) in lung cancer treatment

Ethynylphosphonamidates in the Synthesis of Antibody–Drug Conjugates

Orthogonal Cysteine Protection Enables Homogeneous Multi‐Drug Antibody–Drug Conjugates

Safety and Tolerability of Antibody-Drug Conjugates in Cancer

Antibody–drug conjugates as an emerging therapy in oncodermatology

Antibody–drug conjugates in the treatment of lymphoid neoplasms

Potential of antibody–drug conjugates (ADCs) for cancer therapy

Antibody–drug conjugates in ovarian cancer

Antibody–drug conjugates—the magic bullet?

Current Status: Site-Specific Antibody Drug Conjugates

Fate of Antibody-Drug Conjugates in Cancer Cells

Antibody–drug conjugates (ADCs) in lung cancer treatment

Ethynylphosphonamidates in the Synthesis of Antibody–Drug Conjugates

Orthogonal Cysteine Protection Enables Homogeneous Multi‐Drug Antibody–Drug Conjugates

Safety and Tolerability of Antibody-Drug Conjugates in Cancer

Antibody–drug conjugates as an emerging therapy in oncodermatology

Antibody–drug conjugates in the treatment of lymphoid neoplasms

Potential of antibody–drug conjugates (ADCs) for cancer therapy

Antibody–drug conjugates in ovarian cancer

Antibody–drug conjugates—the magic bullet?

Current Status: Site-Specific Antibody Drug Conjugates

Fate of Antibody-Drug Conjugates in Cancer Cells

Antibody–drug conjugates (ADCs) in lung cancer treatment

Ethynylphosphonamidates in the Synthesis of Antibody–Drug Conjugates

Orthogonal Cysteine Protection Enables Homogeneous Multi‐Drug Antibody–Drug Conjugates

Safety and Tolerability of Antibody-Drug Conjugates in Cancer

Antibody–drug conjugates as an emerging therapy in oncodermatology

Antibody–drug conjugates in the treatment of lymphoid neoplasms

Potential of antibody–drug conjugates (ADCs) for cancer therapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Antibody Drug Conjugates

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Antibody–drug conjugates in ovarian cancer

Antibody–drug conjugates—the magic bullet?

Current Status: Site-Specific Antibody Drug Conjugates

Fate of Antibody-Drug Conjugates in Cancer Cells

Antibody–drug conjugates (ADCs) in lung cancer treatment

Ethynylphosphonamidates in the Synthesis of Antibody–Drug Conjugates

Orthogonal Cysteine Protection Enables Homogeneous Multi‐Drug Antibody–Drug Conjugates

Orthogonal Cysteine Protection Enables Homogeneous Multi‐Drug Antibody–Drug Conjugates

Safety and Tolerability of Antibody-Drug Conjugates in Cancer

Antibody–drug conjugates as an emerging therapy in oncodermatology

Antibody–drug conjugates in the treatment of lymphoid neoplasms

Potential of antibody–drug conjugates (ADCs) for cancer therapy

Antibody–drug conjugates in ovarian cancer

Antibody–drug conjugates—the magic bullet?

Current Status: Site-Specific Antibody Drug Conjugates

Fate of Antibody-Drug Conjugates in Cancer Cells

Antibody–drug conjugates (ADCs) in lung cancer treatment

Ethynylphosphonamidates in the Synthesis of Antibody–Drug Conjugates

Orthogonal Cysteine Protection Enables Homogeneous Multi‐Drug Antibody–Drug Conjugates

Orthogonal Cysteine Protection Enables Homogeneous Multi‐Drug Antibody–Drug Conjugates

Safety and Tolerability of Antibody-Drug Conjugates in Cancer

Antibody–drug conjugates as an emerging therapy in oncodermatology

Antibody–drug conjugates in the treatment of lymphoid neoplasms

Potential of antibody–drug conjugates (ADCs) for cancer therapy

Antibody–drug conjugates in ovarian cancer

Antibody–drug conjugates—the magic bullet?

Current Status: Site-Specific Antibody Drug Conjugates

Fate of Antibody-Drug Conjugates in Cancer Cells

Antibody–drug conjugates (ADCs) in lung cancer treatment

Ethynylphosphonamidates in the Synthesis of Antibody–Drug Conjugates

Orthogonal Cysteine Protection Enables Homogeneous Multi‐Drug Antibody–Drug Conjugates

Orthogonal Cysteine Protection Enables Homogeneous Multi‐Drug Antibody–Drug Conjugates

Safety and Tolerability of Antibody-Drug Conjugates in Cancer

Antibody–drug conjugates as an emerging therapy in oncodermatology

Antibody–drug conjugates in the treatment of lymphoid neoplasms

Potential of antibody–drug conjugates (ADCs) for cancer therapy

Related objects

Reset password